Ocular Cysticercosis

Ocular Cysticercosis

No Results

No Results

processing….

Cysticercus cellulosae, the larval form of the pork tapeworm Taenia solium, is the causative organism of cysticercosis, in which humans are the intermediate hosts in the life cycle. Cysticercus cellulosae may become encysted in various bodily tissues, usually the eyes, central nervous system (CNS), and subcutaneous tissues. An immunologic reaction with fairly intense inflammatory signs and symptoms may be produced, and the surrounding structures may be compressed.

Ocular cysticercosis may be extraocular (in the subconjunctival or orbital tissues) or intraocular (in the vitreous, subre­tinal space, or anterior chamber). [1, 2, 3, 4, 5, 6, 7]

Humans are the intermediate hosts for T solium, and pigs are the definitive hosts. [8] A tapeworm larval cyst (cysticercus) is ingested with poorly-cooked infected pork; the larva escapes the cyst and passes to the small intestine, where it attaches to the mucosa with scolex suckers. Egg-containing proglottids develop as the worm matures in 3-4 months. The adult worm may live in the small intestine for as long as 25 years without symptoms (taeniasis) and pass gravid proglottids intermittently with the feces. Eggs extruded from the proglottid contaminate and persist on vegetation, where pigs consume them. T solium embryos penetrate the gastrointestinal mucosa of the animal host and are then hematogenously disseminated to peripheral tissues with the resultant formation of larval cysts (cysticerci).

Human cysticercosis occurs when T solium eggs are ingested via fecal-oral transmission from a tapeworm host. The human then becomes an accidental intermediate host. These oncospheres (primary larvae) penetrate the intestinal mucosa and enter the circulatory system. Hematogenous spread to neural, muscular, and ocular tissues occurs. Within these tissues, the oncospheres develop into secondary larvae (ie, the cysticerci).

The incubation period may vary from months to years. The host inflammatory response to cysticerci depends on the parasite’s ability to evade host immunity; therefore, inflammation is restricted to degenerating cysts whose ability to evade host defenses is faltering. Lack of inflammation occurs with both healthy cysticerci (active disease) and those that have involuted (inactive disease). Upon involution, cysts undergo granulomatous change and exhibit calcification.

United States

The incidence in the United States is increasing secondary to increased immigration from endemic areas, increased travel to endemic areas, and improved serologic testing and availability of diagnostic imaging. An estimated 1000 new cases per year are diagnosed in the United States.

International

Cysticercosis affects an estimated 50 million people worldwide. Ocular cysticercosis is endemic in tropical areas, such as sub-Saharan Africa, India, and East Asia. Other endemic areas include Mexico and Latin America. The reported incidence of ocular involvement varies from 10-30% in endemic areas. Some European studies report a higher incidence of ocular cysticercosis than neurocysticercosis. In Western countries, [9] the most common site of involvement in ocular cysticercosis is subretinal. In India, both intraocular cysticercosis and extraocular cysticercosis is observed with almost equal frequency.

Cysticercosis may cause significant visual loss, especially if the cyst is located intraocularly or is compressing the optic nerve.

The incidence is more common in the Asian and Latin American populations, in which cysticercosis is endemic.

There is no specific sex predilection.

Orbital cysticercosis most frequently affects individuals aged 10-30 years. [10]

With adequate treatment, the prognosis is good in most individuals with orbital cysticercosis as the cyst resolves. Medical therapy, consisting of oral albendazole and corticosteroids, can arrest recurrent inflammation and improve ocular motility.

Intraocular cysticercosis may lead to blindness due to the severity of induced inflammation. Cysticerci compressing the optic nerve may also cause blindness.

Family members should be screened for infection.

Murthy GR, Rao AV. Sub-conjunctival cysticercosis. Indian J Ophthalmol. 1980 Jul. 28(2):77-8. [Medline].

Ziaei M, Elgohary M, Bremner FD. Orbital cysticercosis, case report and review. Orbit. 2011 Oct. 30(5):230-5. [Medline].

Rath S, Honavar SG, Naik M, Anand R, Agarwal B, Krishnaiah S, et al. Orbital cysticercosis: clinical manifestations, diagnosis, management, and outcome. Ophthalmology. 2010 Mar. 117(3):600-5, 605.e1. [Medline].

Sharma M, Beke N, Khurana S, Bhatti HS, Sehgal R, Malla N. An ocular cysticercosis case: Caused by Asian genotype of Taenia solium. Indian J Med Microbiol. 2015 Oct-Dec. 33 (4):583-5. [Medline].

Ding J, Zhao H, Lin J. Surgical Excision of Orbital Cysticercosis Lodged in Superior Oblique Muscle: Clinical Case Report. Medicine (Baltimore). 2015 Jul. 94 (30):e1026. [Medline].

Goyal S, Sandhu PS, Sharma A, Malik MA, Bansal P, Kaur J. Inferior rectus muscle ocular cysticercosis: A case report. Saudi J Ophthalmol. 2015 Apr-Jun. 29 (2):175-7. [Medline].

Raoot A. Lacrimal sac cysticercosis: a rare site for manifestation. Case Rep Ophthalmol Med. 2014. 2014:961815. [Medline].

Li JJ, Zhang LW, Li H, Hu ZL. Clinical and pathological characteristics of intraocular cysticercosis. Korean J Parasitol. 2013 Apr. 51(2):223-9. [Medline]. [Full Text].

Bartholomew RS. Subretinal Cysticercosis. Am J Ophthalmol. 1975. 79:670-73.

Cantor LB, Rapuano CJ, Cioffi GA. Infectious ocular inflammation. Moorthy RS, Rao PK, Read RW, Gelder RNV, Vitale AT, Bodaghi B, Parrish CM. Basic and Clinical Science Course. 2014-2015. San Francisco: American Academy of Ophthalmology; 2014. 9: 370.

Topilow HW, Yimoyines DJ, Freeman HM, et al. Bilateral multifocal intraocular cysticercosis. Ophthalmology. 1981 Nov. 88(11):1166-72. [Medline].

Kapoor S, Kapoor MS. Ocular cysticercosis. J Pediatr Ophthalmol Strabismus. 1978 May-Jun. 15(3):170-3. [Medline].

Sharma T, Sinha S, Shah N, et al. Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery. Ophthalmology. 2003 May. 110(5):996-1004. [Medline].

Sandeep Saxena. Uveitis. Clinical Ophthalmology. 2nd. New Delhi, India: Jaypee Brothers Medical Publishers; 2011. 877.

Messner KH, Kammerer WS. Intraocular cysticercosis. Arch Ophthalmol. 1979 Jun. 97(6):1103-5. [Medline].

Wood TR, Binder PS. Intravitreal and intracameral cysticercosis. Ann Ophthalmol. 1979 Jul. 11(7):1033-6. [Medline].

Seo MS, Woo JM, Park YG. Intravitreal cysticercosis. Korean J Ophthalmol. 1996 Jun. 10(1):55-9. [Medline].

Jain IS, Dhir SP, Chattopadhaya PR, Kumar P. Ocular cysticercosis in North India. Indian J Ophthalmol. 1979 Jul. 27(2):54-8. [Medline].

Chandra A, Singh MK, Singh VP, et al. A live cysticercosis in anterior chamber leading to glaucoma secondary to pupilary block. J Glaucoma. 2007 Mar. 16(2):271-3. [Medline].

Sachdeva RS, Manchanda SK, Abrol S, et al. Freely mobile cysticercus in the anterior chamber. Indian J Ophthalmol. 1995 Sep. 43(3):135-6. [Medline].

Adegbehingbe BO, Soetan EO, Adeoye AO. Case report: intraocular cysticercosis. West Afr J Med. 2003 Dec. 22(4):354-5. [Medline].

Chand K, Srivastava SK. Spontaneous expulsion of subconjunctival Cysticercus cellulosae. MJAFI. 2006. 62:188-9.

Mohan K, Saroha V, Sharma A, et al. Extraocular muscle cysticercosis: clinical presentations and outcome of treatment. J Pediatr Ophthalmol Strabismus. 2005 Jan-Feb. 42(1):28-33. [Medline].

Bansal RK, Gupta A, Grewal SP, et al. Spontaneous extrusion of cysticercosis: report of three cases. Indian J Ophthalmol. 1992 Apr-Jun. 40(2):59-60. [Medline].

Sundaram PM, Jayakumar N, Noronha V. Extraocular muscle cysticercosis – a clinical challenge to the ophthalmologists. Orbit. 2004 Dec. 23(4):255-62. [Medline].

Labh RK, Sharma AK. Ptosis: a rare presentation of ocular cysticercosis. Nepal J Ophthalmol. 2013 Jan. 5(9):133-5. [Medline].

Sudan R, Muralidhar R, Sharma P. Optic nerve cysticercosis: case report and review of current management. Orbit. 2005 Jun. 24(2):159-62. [Medline].

Foster, Stephen; Vitale, Albert. Cysticercosis. Uveitis. 2nd. New Delhi, India: Jaypee-Brothers Medical Publishers; 2013. 1290.

Honavar SG, Sekhar CG. Ultrasonological characteristics of extraocular cysticercosis. Orbit. 1998 Dec. 17(4):271-284. [Medline].

Atul K, Kumar TH, Mallika G, et al. Socio-demographic trends in ocular cysticercosis. Acta Ophthalmol Scand. 1995 Oct. 73(5):438-41. [Medline].

Tripathy SK, Sen RK, Akkina N, Hampannavar A, Tahasildar N, Limaye R. Role of ultrasonography and magnetic resonance imaging in the diagnosis of intramuscular cysticercosis. Skeletal Radiol. 2011 Nov 19. [Medline].

Sekhar GC, Honavar SG. Myocysticercosis: experience with imaging and therapy. Ophthalmology. 1999 Dec. 106(12):2336-40. [Medline].

Pushker N, Bajaj MS, Chandra M, et al. Ocular and orbital cysticercosis. Acta Ophthalmol Scand. 2001 Aug. 79(4):408-13. [Medline].

Kaur A, Agrawal A, Agrawal PK, et al. Lacrimal canalicular obstruction by cysticercus cellulosae. Orbit. 2006 Jun. 25(2):163-5. [Medline].

Sekhar GC, Lemke BN. Orbital cysticercosis. Ophthalmology. 1997 Oct. 104(10):1599-604. [Medline].

Beri S, Vajpayee RB, Dhingra N, et al. Managing anterior chamber cysticercosis by viscoexpression: a new surgical technique. Arch Ophthalmol. 1994 Oct. 112(10):1279-80. [Medline].

Das JC, Chaudhuri Z, Bansal RL, et al. Viscoexpression of anterior chamber cysticercus cellulosae. Indian J Ophthalmol. 2002 Jun. 50(2):133-5. [Medline].

Natarajan S, Malpani A, Kumar Nirmalan P, Dutta B. Management of intraocular cysticercosis. Graefes Arch Clin Exp Ophthalmol. 1999 Oct. 237(10):812-4. [Medline].

Santos R, Dalma A, Ortiz E, et al. Management of subretinal and vitreous cysticercosis: role of photocoagulation and surgery. Ophthalmology. 1979 Aug. 86(8):1501-7. [Medline].

Jean Deschênes, MD, FRCSC Professor, Research Associate, Director, Uveitis Program, Department of Ophthalmology, McGill University Faculty of Medicine; Senior Ophthalmologist, Clinical Director, Department of Ophthalmology, Royal Victoria Hospital, Canada

Jean Deschênes, MD, FRCSC is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, Canadian Medical Association, Canadian Ophthalmological Society, International Ocular Inflammation Society, Quebec Medical Association

Disclosure: Nothing to disclose.

Christian El-Hadad, MD, CM, FRCSC Fellow, Orbital Oncology, Ophthalmic Plastic and Reconstructive Surgery, University of Texas MD Anderson Cancer Center

Christian El-Hadad, MD, CM, FRCSC is a member of the following medical societies: American Academy of Ophthalmology, Canadian Ophthalmological Society

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Glaucoma Society

Disclosure: Nothing to disclose.

Hampton Roy, Sr, MD Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy, Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Richard W Allinson, MD Associate Professor, Department of Ophthalmology, Texas A&M University Health Science Center; Senior Staff Ophthalmologist, Scott and White Clinic

Richard W Allinson, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, Texas Medical Association

Disclosure: Nothing to disclose.

Smita Menon-Mehta, MBBS, DO, FRCS(Glasg) Consulting Staff, Department of Ophthalmology, Bahrain Specialist Hospital

Smita Menon-Mehta, MBBS, DO, FRCS(Glasg) is a member of the following medical societies: All India Ophthalmological Society

Disclosure: Nothing to disclose.

Ocular Cysticercosis

Research & References of Ocular Cysticercosis|A&C Accounting And Tax Services
Source